Hye Sang Park

9PUBLICATIONS
25CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Clinical pharmacology and therapeuticsGeomorphology and earth surface processesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 27, 2026
Immunological Biomarkers to Assess Activity and Treatment Response in IgG4-Related Disease.

Patricia Moya-Alvarado, Marta Lopez-Gomez, Laura Martínez-Martinez

|Nov 27, 2024
Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice.

Marta Lopez-Gomez, Patricia Moya-Alvarado, Hye Sang Park

|Apr 27, 2024
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?

Cristina Martinez-Molina, Anna Feliu, Hye S Park

|Apr 16, 2024
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort.

Helena Codes-Méndez, Luis Sainz, Hye Sang Park

|Mar 28, 2024
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis.

Cristina Martinez-Molina, Cesar Diaz-Torne, Hye S Park

|Jan 03, 2024
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study.

Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné

Pageof 2

Frequent Collaborators

8 joint publications

Hèctor Corominas

6 joint publications

César Díaz-Torné

3 joint publications

Patricia Moya-Alvarado

3 joint publications

Ivan Castellví